Company Filing History:
Years Active: 2004-2010
Title: Ella Evron: Innovator in Breast Cancer Diagnosis
Introduction: Ella Evron, based in Baltimore, MD, has made significant contributions to the field of cancer diagnosis through her innovative research. With three patents to her name, her work focuses on the intricacies of gene methylation and its implications for breast malignancy.
Latest Patents: Among her latest inventions, Ella Evron has developed a method for diagnosing cell proliferative disorders of breast tissue. Her patent titled "Aberrantly Methylated Genes as Markers of Breast Malignancy" emphasizes the determination of the methylation status of nucleic acids obtained from subjects. The invention identifies aberrant methylation of multiple genes, including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RARβ), estrogen receptor (ER), cyclin D2, WT-1, 14.3.3 sigma, HIN-1, RASSF1A, and various combinations of these genes as reliable markers for breast malignancy.
Career Highlights: Ella Evron is currently affiliated with The Johns Hopkins University, where her research has garnered attention for its potential to improve breast cancer diagnosis. Her innovative approaches have positioned her as a key player in the medical research community.
Collaborations: Throughout her career, Ella has collaborated with esteemed colleagues such as Saraswati Vaidyanathan Sukumar and William C. Dooley. These partnerships have enhanced her research and contributed to the advancement of cancer diagnostic methods.
Conclusion: Ella Evron's pioneering work in the field of breast cancer diagnosis showcases her commitment to innovation and improving patient care. Her patents reflect a profound understanding of genetics and its application in medicine, making her a valuable asset to the scientific community.